Lyka Labs Limited Q1 Revenue Rises 28% Ahead of Q2 Results

Lyka Labs Limited reported consolidated revenue from operations of ₹42.31 crore for the quarter ended June 30, 2026, up 28.11% year-on-year from ₹33.03 crore. Consolidated profit after tax reached ₹2.05 crore, more than double the prior-year figure and a reversal from the ₹8.07 crore loss reported in the March 2026 quarter.

What did Lyka Labs report for the June 2026 quarter?

Lyka Labs reported an improvement in its consolidated financial performance during the June 2026 quarter, which was the first quarter of FY27. Revenue from operations was ₹42.31 crore, while consolidated profit after tax was ₹2.05 crore. The revenue figure represented a 28.11% increase from ₹33.03 crore in the corresponding quarter of the previous year.

The June-quarter result also marked a sequential recovery from the March 2026 quarter. Consolidated revenue in March stood at ₹28.03 crore, compared with ₹42.31 crore in June. The company moved from a consolidated loss of ₹8.07 crore in the March quarter to a profit of ₹2.05 crore in the June quarter.

The reported quarterly highlights also placed revenue at ₹42.73 crore and operating profit at ₹1.95 crore, with earnings per share of ₹2.81 for June 2026. Financial databases can present standalone and consolidated figures differently, and the company’s result update specifically reported consolidated revenue of ₹42.31 crore and consolidated profit after tax of ₹2.05 crore.

Why is Lyka Labs holding a board meeting on October 30?

Lyka Labs will hold a meeting of its Board of Directors on October 30, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The meeting is the company’s scheduled Q2 FY27 results event.

The board will also consider the limited review report issued by the statutory auditor. After approval, the company has stated that the financial results will be made available on its website. The scheduled date follows the release of Q1 FY27 results on August 10, 2026.

The October disclosure will provide the next official update on whether the June-quarter improvement in revenue and profitability continued through the September quarter. Until those numbers are approved by the board, the available financial information is limited to the company’s earlier filings and reported June-quarter performance.

How does the June-quarter result compare with Lyka Labs' earlier performance?

Lyka Labs' June-quarter recovery followed a weaker March 2026 period. Consolidated March-quarter net sales were ₹28.03 crore, down 16.15% year-on-year, according to the reported financial updates. The June-quarter revenue increase therefore represented a material sequential improvement in the reported sales level.

For FY26, Lyka Labs reported revenue of ₹131.94 crore, compared with ₹140.73 crore in FY25, a year-on-year decline of 6.25%. It also reported an operating loss of ₹11.78 crore in FY26, against an operating loss of ₹11.12 crore in FY25. These annual figures provide context for the importance of a return to quarterly profitability in June.

The standalone result reported separately showed net profit of ₹2.10 crore for the quarter ended June 30, 2026, compared with ₹0.81 crore in the corresponding period a year earlier. The difference between this figure and consolidated profit reflects the separate reporting bases, rather than a single interchangeable profit number.

What does the result mean for investors and operations?

The June-quarter numbers show higher revenue and a return to consolidated profit after the March-quarter loss. For investors, the key reported changes are the 28.11% year-on-year increase in consolidated revenue and the move from an ₹8.07 crore loss in March to ₹2.05 crore profit in June.

The supplied June-quarter disclosure attributed the revenue improvement to growth in exports and domestic sales. It referred to export growth of 68.03% and a 15.91% rise in domestic sales. These figures indicate that both reported sales channels contributed to the quarter’s revenue growth.

However, the annual FY26 revenue decline and operating loss show that the company’s financial performance had remained under pressure over the full year. The September-quarter results will be relevant because they will provide the first half-year update after the June recovery. No share-price movement, dividend decision, or operational forecast was disclosed in the provided information.

Conclusion

Lyka Labs Limited entered the October 30 results event after reporting higher June-quarter revenue and a return to consolidated profitability. Revenue from operations rose to ₹42.31 crore, while consolidated profit after tax reached ₹2.05 crore, compared with ₹1.00 crore a year earlier and a loss of ₹8.07 crore in the preceding quarter.

The next item to watch is the board’s approval of the unaudited Q2 FY27 and half-year results for the period ended September 30, 2026. The company is also scheduled to present its statutory auditor’s limited review report, with the approved results to be published on its website.